Skip to main content

Table 1 Patients characteristics at the cross-sectional phase visit

From: 1-year prospective real life monitoring of asthma control and quality of life in Italy

  Total Partly controlled Uncontrolled
Number of patients, n (%) 1017 (100) 451 (44.3) 566 (55.7)
Age, years, mean (SD) 46 (15) 45 (15) 47 (15)
Gender, n (%)    
  Males 343 (33.7) 160 (35.5) 183 (32.3)
  Females 674 (66.3) 291 (64.5) 383 (67.7)
Duration of asthma, years, mean (SD) 17.4 (13.0) 16.4 (12.7) 18.2 (13.2)
Body mass index categories, n (%)    
  Obese (≥ 30 kg/m2) (1) 201 (19.8) 75 (16.6) 126 (22.3)
  Overweight (≥ 25 and < 30 kg/m2) 357 (35.1) 162 (35.9) 195 (34.5)
  Normal weight (≥ 18.5 and < 25 kg/m2) 390 (38.4) 188 (41.7) 202 (35.7)
  Underweight (< 18.5 kg/m2) 32 (3.2) 12 (2.7) 20 (3.5)
  Not available 37 (3.6) 14 (3.1) 23 (4.1)
Smoking habits, n (%)    
  Current smokers 197 (19.4) 77 (17.1) 120 (21.2)
  Non-smokers 637 (62.6) 287 (63.6) 350 (61.8)
  Ex-smokers (2) 174 (17. 1) 86 (19.1) 88 (15.6)
  Not available 9 (0.9) 1 (0.2) 8 (1.4)
Concomitant diseases (3), n (%)    
  Total 640 (62.9) 287 (63.6) 353 (62.4)
  Rhinitis 362 (35.6) 164 (36.4) 198 (35.0)
  Cardiovascular diseases 151 (14.8) 70 (15.5) 81 (14.3)
  Gastro-oesophageal reflux 171 (16.8) 68 (15.1) 103 (18.2)
  Sinusitis (4) 114 (11.2) 38 (8.4) 76 (13.4)
  Nasal polyposis 52 (5.1) 25 (5.5) 27 (4.8)
  Type 2 diabetes 39 (3.8) 14 (3.1) 25 (4.4)
  Respiratory infections 43 (4.2) 15 (3.3) 28 (5.0)
  Psychological disturbances 25 (2.5) 9 (2.0) 16 (2.8)
  Type 1 diabetes 5 (0.5) 2 (0.4) 3 (0.5)
  Other diseases 108 (10.6) 42 (9.3) 66 (11.7)
Quality of life, n 1010 448 562
  EQ-5D (5) score, mean (SD) 0.72 (0.2) 0.75 (0.2) 0.69 (0.2)
  EQ-5D (5) VAS score, mean (SD) 65.1 (15.6) 68.6 (14.9) 61.5 (16.3)
  1. (1) Overall p = 0.021; (2) Patients who stopped smoking since at least one year; (3) Patients could have more than one concomitant disease; (4) Overall p = 0.012; (5) EQ-5D: EuroQoL-5D questionnaire.